{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:15:57Z","timestamp":1789398957223,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":3342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kompetenznetz"},{"name":"Maligne Lymphome"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1093\/annonc\/mdq066","type":"journal-article","created":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T01:39:46Z","timestamp":1269049186000},"page":"2052-2060","source":"Crossref","is-referenced-by-count":141,"title":["No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group"],"prefix":"10.1016","volume":"21","author":[{"given":"K.","family":"Behringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Mattle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ganitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"van den Hoonaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W.","family":"Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pluetschow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq066_bb0010","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1200\/JCO.2008.19.8820","article-title":"Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin\u2019s lymphoma: 10 years of follow-up of the GHSG HD9 study","volume":"27","author":"Engert","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq066_bb0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/archinte.1974.00320240073007","article-title":"Hodgkin disease in Connecticut from 1935 to 1962. The bimodal incidence curve in the general population and survival in untreated patients","volume":"134","author":"Greco","year":"1974","journal-title":"Arch Intern Med"},{"key":"10.1093\/annonc\/mdq066_bb0020","doi-asserted-by":"crossref","first-page":"p2080","DOI":"10.1093\/oxfordjournals.humrep.a137985","article-title":"Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin\u2019s disease","volume":"8","author":"Familiari","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0025","doi-asserted-by":"crossref","first-page":"p65","DOI":"10.3109\/10428199909093726","article-title":"Ovarian injury and modern options to preserve fertility in female cancer patients treated with high dose radio-chemotherapy for hemato-oncological neoplasias and other cancers","volume":"33","author":"Meirow","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdq066_bb0030","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/1097-0142(19830915)52:6<988::AID-CNCR2820520610>3.0.CO;2-6","article-title":"The effect of combination chemotherapy on ovarian function in women treated for Hodgkin\u2019s disease","volume":"52","author":"Whitehead","year":"1983","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq066_bb0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/0002-9343(81)90205-9","article-title":"Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease","volume":"71","author":"Schilsky","year":"1981","journal-title":"Am J Med"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mdq066_bb0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/annonc\/3.suppl_4.S105","article-title":"Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP\/ABVD chemotherapy for Hodgkin's disease","volume":"3","author":"Kreuser","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq066_bb0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood-2007-05-090225","article-title":"Treatment-related risk factors for premature menopause following Hodgkin lymphoma","volume":"111","author":"De Bruin","year":"2008","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdq066_bb0050","doi-asserted-by":"crossref","first-page":"7555","DOI":"10.1200\/JCO.2005.08.138","article-title":"Secondary amenorrhea after Hodgkin\u2019s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group","volume":"23","author":"Behringer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq066_bb0055","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/humupd\/dmn022","article-title":"GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy","volume":"14","author":"Blumenfeld","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1093\/annonc\/mdq066_bb0060","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/humupd\/dmn041","article-title":"GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data","volume":"14","author":"Beck-Fruchter","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1093\/annonc\/mdq066_bb0065","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1634\/theoncologist.12-9-1055","article-title":"Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury","volume":"12","author":"Oktay","year":"2007","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq066_bb0070","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1200\/JCO.2006.06.5888","article-title":"American Society of Clinical Oncology recommendations on fertility preservation in cancer patients","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq066_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00254570","article-title":"Failure to preserve fertility in patients with Hodgkin's disease","volume":"19","author":"Waxman","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1093\/annonc\/mdq066_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10245330600954072","article-title":"Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD)","volume":"12","author":"Giuseppe","year":"2007","journal-title":"Hematology"},{"key":"10.1093\/annonc\/mdq066_bb0085","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.fertnstert.2007.02.010","article-title":"Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma","volume":"89","author":"Blumenfeld","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1093\/annonc\/mdq066_bb0090","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/humrep\/den005","article-title":"Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients","volume":"23","author":"Huser","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0095","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.fertnstert.2006.10.004","article-title":"Use of gonadotropin-releasing hormone agonists in patients with Hodgkin\u2019s disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy","volume":"87","author":"Castelo-Branco","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1093\/annonc\/mdq066_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/09513590400027414","article-title":"Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin\u2019s disease undergoing chemotherapy","volume":"20","author":"Franke","year":"2005","journal-title":"Gynecol Endocrinol"},{"key":"10.1093\/annonc\/mdq066_bb0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","article-title":"Anti-mullerian hormone as a marker of ovarian reserve","volume":"45","author":"Tremellen","year":"2005","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1093\/annonc\/mdq066_bb0110","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/humrep\/del201","article-title":"The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer","volume":"21","author":"Anderson","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0115","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.2007-2093","article-title":"Relationship of serum antimullerian hormone concentration to age at menopause","volume":"93","author":"van Disseldorp","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdq066_bb0120","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2008-0567","article-title":"Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition","volume":"93","author":"Sowers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdq066_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/rep.1.00529","article-title":"Anti-Mullerian hormone: a new marker for ovarian function","volume":"131","author":"Visser","year":"2006","journal-title":"Reproduction"},{"key":"10.1093\/annonc\/mdq066_bb0135","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2006-2374","article-title":"Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin\u2019s lymphoma during childhood","volume":"92","author":"van Beek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdq066_bb0140","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/humrep\/dem101","article-title":"Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women","volume":"22","author":"Tsepelidis","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0145","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1200\/JCO.2006.06.9823","article-title":"Measuring the impact of chemotherapy on fertility in women with breast cancer","volume":"24","author":"Oktay","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq066_bb0150","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/den487","article-title":"Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone","volume":"24","author":"Lie Fong","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/humupd\/dmh052","article-title":"Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing","volume":"11","author":"Lutchman Singh","year":"2005","journal-title":"Hum Reprod Update"},{"key":"10.1093\/annonc\/mdq066_bb0160","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/annonc\/mdl149","article-title":"Treatment-related premature ovarian failure as a long-term complication after Hodgkin\u2019s lymphoma","volume":"17","author":"Haukvik","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq066_bb0165","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.thj.6200248","article-title":"Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas","volume":"4","author":"Franchi-Rezgui","year":"2003","journal-title":"Hematol J"},{"key":"10.1093\/annonc\/mdq066_bb0170","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1093\/humrep\/deg473","article-title":"Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Mullerian hormone, inhibin B and ovarian ultrasound","volume":"18","author":"Bath","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0175","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","article-title":"Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study","volume":"91","author":"Badawy","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1093\/annonc\/mdq066_bb0180","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.fertnstert.2007.09.048","article-title":"Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers","volume":"90","author":"Reh","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1093\/annonc\/mdq066_bb0185","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/13.6.1442","article-title":"Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years","volume":"13","author":"Schipper","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1093\/annonc\/mdq066_bb0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jncimonographs\/lgi017","article-title":"Defining and measuring reproductive concerns of female cancer survivors","volume":"34","author":"Wenzel","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1093\/annonc\/mdq066_bb0195","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1210\/jc.2003-030352","article-title":"Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer","volume":"88","author":"Larsen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1093\/annonc\/mdq066_bb0200","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(92)91335-8","article-title":"Early menopause in long-term survivors of cancer during adolescence","volume":"166","author":"Byrne","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1093\/annonc\/mdq066_bb0205","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/jnci\/djj243","article-title":"Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"98","author":"Sklar","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdq066_bb0210","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1200\/JCO.2003.06.028","article-title":"14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin\u2019s lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group","volume":"21","author":"Sieber","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq066_bb0215","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(04)17222-X","article-title":"Livebirth after orthotopic transplantation of cryopreserved ovarian tissue","volume":"364","author":"Donnez","year":"2004","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdq066_bb0220","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1634\/theoncologist.12-12-1437","article-title":"Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease","volume":"12","author":"Demeestere","year":"2007","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq066_bb0225","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ejca.2009.01.029","article-title":"Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy\u2014a technique in its infancy but already successful in fertility preservation","volume":"45","author":"von Wolff","year":"2009","journal-title":"Eur J Cancer"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419395730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419395730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/10\/2052\/901048\/mdq066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:12:55Z","timestamp":1624518775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419395730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0923753419395730"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq066","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}